atorvastatin has been researched along with Thromboembolism, Venous in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bellomo, T; Boada, AE; Dua, A; Goudot, G; Hall, RP; Jessula, S; Kukreja, N; Lee, I; Majumdar, M; Parmar, G; Suarez Ferreira, SP | 1 |
| Birdal, O; Doğan, R; Karagöz, A; Saygı, M; Tanboğa, İH; Tezen, O | 1 |
| Abedini, A; Amin, A; Bakhshandeh, H; Beigmohammadi, MT; Bikdeli, B; Dabbagh, A; Farrokhpour, M; Goldhaber, SZ; Gupta, A; Hadavand, N; Hajighasemi, A; Jamalkhani, S; Jimenez, D; Khalili, H; Kirtane, AJ; Krumholz, HM; Lip, GYH; Lookzadeh, S; Madhavan, MV; Maleki, M; Matin, S; Mohebbi, B; Monreal, M; Parhizgar, SE; Parikh, SA; Payandemehr, P; Piazza, G; Rashidi, F; Rezaeifar, P; Riahi, T; Sadeghian, S; Sadeghipour, P; Sezavar, H; Shahmirzaei, S; Sharif-Kashani, B; Tahamtan, O; Talasaz, AH; Yadollahzadeh, M | 1 |
| Bartosic, A; Kerlin, BA; Lin, E; Riedl, K; Waller, AP; Wang, TF; Wei, L | 1 |
| Cieśla-Dul, M; Potaczek, DP; Undas, A; Żółciński, M | 1 |
| Ciesla-Dul, M; Undas, A; Zolcinski, M | 1 |
1 review(s) available for atorvastatin and Thromboembolism, Venous
| Article | Year |
|---|---|
Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis
Topics: Atorvastatin; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Network Meta-Analysis; Rosuvastatin Calcium; Venous Thromboembolism | 2023 |
3 trial(s) available for atorvastatin and Thromboembolism, Venous
| Article | Year |
|---|---|
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anticoagulants; Atorvastatin; COVID-19; Critical Care; Double-Blind Method; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Intensive Care Units; Iran; Male; Middle Aged; Odds Ratio; SARS-CoV-2; Treatment Outcome; Venous Thromboembolism; Young Adult | 2022 |
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Topics: Anticoagulants; Atorvastatin; COVID-19; COVID-19 Drug Treatment; Critical Illness; Double-Blind Method; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thrombosis; Time Factors; Treatment Outcome; Venous Thromboembolism | 2020 |
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism.
Topics: Acute Disease; Adult; Aged; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Venous Thromboembolism; Young Adult | 2021 |
3 other study(ies) available for atorvastatin and Thromboembolism, Venous
| Article | Year |
|---|---|
Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Atorvastatin; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome; Venous Thromboembolism | 2023 |
Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosis.
Topics: Atorvastatin; C-Reactive Protein; Cytokines; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukins; P-Selectin; Pyrroles; Venous Thromboembolism | 2013 |
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.
Topics: Atorvastatin; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Dyslipidemias; Fibrin; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Poland; Pyrroles; Treatment Outcome; Ultrasonography, Doppler, Color; Venous Thromboembolism | 2012 |